Management of Hypertension
The optimal approach to manage hypertension includes both lifestyle modifications and pharmacological therapy, with a target blood pressure of <140/90 mmHg for most patients and <130/80 mmHg for high-risk patients with diabetes, renal impairment, or established cardiovascular disease. 1, 2
Blood Pressure Assessment and Targets
Blood Pressure Measurement
- Measure BP following standardized techniques using properly calibrated devices
- Record at least two readings per visit
- Consider out-of-office measurements (home or ambulatory monitoring) to detect white coat or masked hypertension 1
- When using ambulatory readings, mean daytime pressures are approximately 10/5 mmHg lower than office readings 1
Blood Pressure Targets
- For most patients: ≤140/90 mmHg 1
- For high-risk patients (diabetes, renal impairment, established cardiovascular disease): ≤130/80 mmHg 1
- For adults ≥85 years: a more lenient target (<140/90 mmHg) may be appropriate 2
Lifestyle Modifications
Lifestyle modifications are the cornerstone of hypertension management and should be implemented for all patients:
- Aim for BMI 20-25 kg/m²
- Target waist circumference <94 cm in men and <80 cm in women
- Each 1 kg of weight loss can reduce systolic BP by approximately 1 mmHg
- Follow DASH diet (rich in fruits, vegetables, low-fat dairy)
- Reduce sodium intake (<2,300 mg/day)
- Increase potassium intake (3,500-5,000 mg/day)
- Reduce saturated and total fat intake
- 150-300 minutes/week of moderate-intensity aerobic exercise
- Include resistance training 2-3 sessions per week
- Consider isometric exercises like hand-grip training
- Men: ≤21 units per week with alcohol-free days
- Women: ≤14 units per week with alcohol-free days
- Complete cessation is strongly recommended
Stress management 2
- Consider cognitive behavioral techniques for stress reduction
Pharmacological Therapy
When to Initiate Drug Therapy
- Systolic BP ≥160 mmHg or diastolic BP ≥100 mmHg despite lifestyle measures 1
- Systolic BP 140-159 mmHg or diastolic BP 90-99 mmHg with target organ damage, established cardiovascular disease, diabetes, or 10-year cardiovascular risk ≥20% 1
First-Line Medications
The following classes have demonstrated cardiovascular event reduction in patients with hypertension:
- Angiotensin-converting enzyme (ACE) inhibitors (e.g., lisinopril) 1, 3
- Angiotensin receptor blockers (ARBs) 1
- Calcium channel blockers (CCBs) (e.g., amlodipine) 1, 4
- Thiazide or thiazide-like diuretics 1
Special Considerations
- For patients with albuminuria (UACR ≥30 mg/g): ACE inhibitors or ARBs as first-line therapy 1
- For patients with established coronary artery disease: ACE inhibitors or ARBs as first-line therapy 1
- For resistant hypertension: consider adding spironolactone, eplerenone, or amiloride 2
- Avoid combinations of ACE inhibitors with ARBs 1
Monitoring and Follow-up
- Monthly follow-up until target BP is achieved 2
- Home BP monitoring to identify patterns and assess treatment effectiveness 1, 2
- Monitor for medication adherence, which affects 10-80% of hypertensive patients 2
- Check renal function and potassium within 1-2 weeks of initiating ACE inhibitors or ARBs 2
- BP-lowering treatment should be maintained lifelong if well tolerated 2
Common Pitfalls to Avoid
Inadequate BP measurement
- Ensure proper technique, cuff size, and patient positioning
- Consider white coat or masked hypertension with out-of-office measurements
Medication non-adherence
- Simplify regimens when possible (once-daily dosing, combination pills)
- Educate patients about the importance of consistent medication use
Overlooking secondary causes
- Consider screening for primary aldosteronism in difficult-to-control or resistant hypertension 1
Ignoring drug interactions
- Be cautious with NSAIDs, which can raise BP
- Monitor potassium levels when using potassium supplements with ACE inhibitors/ARBs
Neglecting orthostatic hypotension
- Measure standing BP in elderly patients
- Note that asymptomatic orthostatic hypotension should not be a reason to withdraw treatment 1
By implementing this comprehensive approach to hypertension management, focusing on both lifestyle modifications and appropriate pharmacological therapy, cardiovascular morbidity and mortality can be significantly reduced.